Vera Therapeutics, Inc. (VERA)
26.97
-1.13
(-4.02%)
USD |
NASDAQ |
Nov 16, 16:00
26.97
0.00 (0.00%)
After-Hours: 19:06
Vera Therapeutics Gross Profit Margin (Quarterly) : 62.84% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 62.84% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -1.67K% |
| Sarepta Therapeutics, Inc. | 49.02% |
| Twist Bioscience Corp. | 53.10% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | 39.18% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -92.54% |
| Return on Assets | -72.27% |
| Return on Invested Capital | -79.13% |
| Profit Margin (Quarterly) | -911.9% |
| Operating Margin (Quarterly) | -931.2% |
| Return on Net Operating Assets | -2.79K% |